Immune cell boost shows promise against Post-Transplant viruses

NCT ID NCT03665675

First seen Nov 19, 2025 · Last updated May 09, 2026 · Updated 21 times

Summary

This study tests whether specially trained white blood cells from a donor can safely fight off cytomegalovirus (CMV) or adenovirus infections in people who have had a stem cell or solid organ transplant. About 20 participants will receive these virus-fighting cells to see if they control the infection without causing serious side effects like graft-versus-host disease. The goal is to offer a new treatment option when standard antiviral drugs fail or cannot be used.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Nationwide Children's Hospital

    RECRUITING

    Columbus, Ohio, 43205, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Ohio State University Comprehensive Cancer Center

    SUSPENDED

    Columbus, Ohio, 43210, United States

Conditions

Explore the condition pages connected to this study.